Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Times Interest Earned (2024 - 2025)

Evommune (EVMN) has disclosed Times Interest Earned for 2 consecutive years, with -$1480.9 as the latest value for Q3 2025.

  • Quarterly Times Interest Earned fell 52.42% to -$1480.9 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$3240.6 through Dec 2025, changed N/A year-over-year, with the annual reading at -$1621.4 for FY2025, 14.31% up from the prior year.
  • Times Interest Earned for Q3 2025 was -$1480.9 at Evommune, down from $21454.0 in the prior quarter.
  • The five-year high for Times Interest Earned was $21454.0 in Q4 2024, with the low at -$1480.9 in Q3 2025.